Monashee Investment Management »

Edgewise Therapeutics shares owned by Monashee Investment Management

Quarter-by-quarter ownership of Edgewise Therapeutics (EWTX) shares owned by Monashee Investment Management from 13F filings

Historical chart of Monashee Investment Management investment in Edgewise Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Edgewise Therapeutics held by Monashee Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Edgewise Therapeutics by Monashee Investment Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.0M 75k 26.69

More positions owned by Monashee Investment Management

Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Core S&p Ttl Stk (ITOT)
Vanguard Index Fds Total Stk Mkt (VTI)
Casella Waste Sys Cl A (CWST)
Aercap Holdings Nv SHS (AER)
Viking Holdings Ord Shs (VIK)
American Healthcare Reit Com Shs (AHR)
Lineage
Sable Offshore Corp Com Shs (SOC)
Newmont Mining Corporation (NEM)

View all positions for Monashee Investment Management

Top funds holding Edgewise Therapeutics

OrbiMed Advisors
RA Capital Management
BlackRock
BlackRock
Baker Bros. Advisors
Novo A/S
Vanguard Group
Cormorant Asset Management
Frazier Life Sciences Management
Paradigm Biocapital Advisors
Henderson Group
Perceptive Advisors
TCG Crossover Management
Braidwell
Driehaus Capital Management

View all funds holding Edgewise Therapeutics